New Clue Shows How Sleeping Sickness Drugs Break Down Key Parasite Protein

Scientists have uncovered a fresh detail in how a promising sleeping sickness drug family works. The drugs are called benzoxaboroles and include acoziborole. Researchers used genetic screens in Trypanosoma brucei the parasite behind African sleeping sickness. They found that exposure caused a rapid short rise in global protein sumoylation. The team did not see direct sumoylation of the target protein CPSF3. Instead the drugs quickly and specifically destabilised CPSF3 in a SUMO and proteasome dependent way. CPSF3 helps process messenger RNA so losing it disrupts parasite gene activity. The result clarifies a shared path for boron based drugs across diverse parasites and could guide stronger safer treatments for neglected tropical disease.

image
advertisement
"We will never ask you to login, or register through a third-party advertisement."